Keyphrases
Adverse Events
20%
Antiepileptic Treatment
60%
Clinical Seizure
80%
Clinical Trials
20%
Confidence Interval
80%
Conventional Treatment
20%
Drug-resistant Epilepsy
20%
Electroencephalography
20%
Electroencephalography Activity
20%
Electrographic Seizures
20%
Epilepsy
100%
Epileptiform
40%
History of Epilepsy
20%
Infantile Spasms
20%
Natural History
40%
Odds Ratio
60%
Open-label Trial
60%
Pooled Analysis
20%
Preventive Treatment
60%
Randomized Controlled Trial
60%
Risk Reduction
20%
Seizure
80%
Treatment Allocation
20%
Tuberous Sclerosis Complex
100%
Video-electroencephalography
20%
Vigabatrin
40%
Medicine and Dentistry
Adverse Event
12%
Anticonvulsant Therapy
37%
Clinical Trial
12%
Drug Resistant Epilepsy
12%
Drug Therapy
12%
Epileptic Seizure
100%
Infantile Spasm
12%
Odds Ratio
37%
Open-Label Trial
37%
Pooled Analysis
12%
Prophylaxis
37%
Randomized Controlled Trial
37%
Tuberous Sclerosis
100%
Vigabatrin
25%
Neuroscience
Anticonvulsant
60%
Artificial Neural Network
20%
Electroencephalography
60%
Open-Label Trial
60%
Randomized Controlled Trial
60%
Tuberous Sclerosis
100%
Vigabatrin
40%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Clinical Trial
20%
Drug Resistant Epilepsy
20%
Infantile Spasm
20%
Open-Label Trial
60%
Randomized Controlled Trial
60%
Tuberous Sclerosis
100%
Vigabatrin
40%